Images List Premium Download Classic

Autoimmune

Autoimmune-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Therapeutic agent for autoimmune diseases comprising pd-1 agonist
Ono Pharmaceutical Co., Ltd.
November 09, 2017 - N°20170320949

Provided is a prophylactic, symptom progress-suppressive, and/or therapeutic agent for an autoimmune disease. The agent lowers the risk of infections and reduces the burden of administration to patients. The prophylactic, symptom progress-suppressive, and/or therapeutic agent includes a pd-1 agonist as an active ingredient and is administered (a) 1 to 10 times within one month from the first administration, (b) in ...
Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
Novo Nordisk A/s
November 09, 2017 - N°20170320946

Novel activating receptors of the ig super-family expressed on human myeloid cells, called trem(s) (triggering receptor expressed on myeloid cells) are provided. Specifically, two (2) members of trems, trem-1 and trem-2 are disclosed. Trem-1 is a transmembrane glycoprotein expressed selectively on blood neutrophils and a subset of monocytes but not on lymphocytes and other cell types and is upregulated by ...
Cytokine-based fusion proteins for treatment of immune disorders
East Carolina University
November 09, 2017 - N°20170320933

The present invention provides fusion proteins including an autoimmune antigen, an allergen antigen or an alloantigen, and an anti-inflammatory cytokine. Compositions and methods including the fusion proteins are also provided.
Autoimmune Patent Pack
Download 462+ patent application PDFs
Autoimmune Patent Applications
Download 462+ Autoimmune-related PDFs
For professional research & prior art discovery
inventor
  • 462+ full patent PDF documents of Autoimmune-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Compositions comprising bacterial strains
4d Pharma Research Limited
November 09, 2017 - N°20170319634

The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases.
Immunosuppressive blood cells and methods of producing the same
Universitatsklinikum Heidelberg
November 09, 2017 - N°20170319619

The present invention refers to a method of producing immunosuppressive bleed cells that can be used for the treatment of autoimmune diseases, in particular multiple sclerosis, organ graft rejection and graft-versus-host disease.
Pharmaceutical compositions containing a pde4 inhibitor and a pi3 delta or dual pi3 delta-gamma kinase ...
Rhizen Pharmaceuticals Sa
November 09, 2017 - N°20170319558

This present invention relates to a method of treating a autoimmune, respiratory and/or inflammatory disease or condition (e. G., psoriasis, rheumatoid arthritis, asthma, copd). The method comprises administering a pi3k delta inhibitor or a dual pi3k delta-gamma inhibitor and a pde4 inhibitor. The present invention also relates to pharmaceutical compositions containing a pi3k delta or dual ...
Autoimmune Patent Pack
Download 462+ patent application PDFs
Autoimmune Patent Applications
Download 462+ Autoimmune-related PDFs
For professional research & prior art discovery
inventor
  • 462+ full patent PDF documents of Autoimmune-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions
Biosuccess Biotech Co. Ltd.
November 02, 2017 - N°20170316169

A method for at least one of characterizing, diagnosing, and treating an autoimmune disorder in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the autoimmune ...
Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions
Biosuccess Biotech Co. Ltd.
November 02, 2017 - N°20170316168

A method for at least one of characterizing, diagnosing, and treating an autoimmune disorder in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the autoimmune ...
Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions
Biosuccess Biotech Co. Ltd.
November 02, 2017 - N°20170316167

A method for at least one of characterizing, diagnosing, and treating an autoimmune disorder in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the autoimmune ...
Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions
Biosuccess Biotech Co. Ltd.
November 02, 2017 - N°20170316166

A method for at least one of characterizing, diagnosing, and treating an autoimmune disorder in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the autoimmune ...
Methods of treating graft versus host disease using il-2 muteins
Biosuccess Biotech Co. Ltd.
November 02, 2017 - N°20170313753

Described herein are immunosuppressive molecules including immunosuppressive variants of il-2, and use of such molecules to treat inflammatory and autoimmune disorders.
Cytokines and neuroantigens for treatment of immune disorders
Biosuccess Biotech Co. Ltd.
November 02, 2017 - N°20170312358

The present invention provides methods of regulating an immunological disorder comprising administering to a subject an effective amount of (i) an autoimmune antigen in conjunction with (ii) an anti-inflammatory cytokine. Compositions including the same are also provided.
Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions
Ubiome, Inc.
October 26, 2017 - N°20170308660

A method for at least one of characterizing, diagnosing, and treating an autoimmune disorder in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the autoimmune ...
Autoimmune Patent Pack
Download 462+ patent application PDFs
Autoimmune Patent Applications
Download 462+ Autoimmune-related PDFs
For professional research & prior art discovery
inventor
  • 462+ full patent PDF documents of Autoimmune-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions
Ubiome, Inc.
October 26, 2017 - N°20170308658

A method for at least one of characterizing, diagnosing, and treating an autoimmune disorder in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the autoimmune ...
Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions
Ubiome, Inc.
October 26, 2017 - N°20170308657

A method for at least one of characterizing, diagnosing, and treating an autoimmune disorder in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the autoimmune ...
Compositions and methods for treating cancer, inflammatory diseases and autoimmune diseases
Gilead Sciences, Inc.
October 26, 2017 - N°20170306050

The present disclosure provides compositions and methods of use comprising a matrix metalloproteinase-9 (mmp9) binding protein, alone or in combination with one or more additional therapeutic agents for the treatment or prevention of diseases and conditions.
Methods of treating autoimmune disease using a domain antibody directed against cd40l
Bristol-myers Squibb Company
October 26, 2017 - N°20170306034

Methods of treating autoimmune diseases, such as primary immune thrombocytopenia (itp), solid organ transplant rejection, graft-related disease, pemphigus vulgaris, systemic sclerosis, and myasthenia gravis using antibody polypeptides that specifically bind human cd40l are provided. The antibody polypeptides do not activate platelets. The methods may comprise at least one administration cycle comprising one dose of the antibody polypeptide. The dose ...
Anti-cd100 antibodies and methods for using the same
Vaccinex, Inc.
October 26, 2017 - N°20170306017

Compositions and methods are provided for treating diseases associated with cd100, including certain autoimmune diseases, inflammatory diseases, and cancers. In particular, anti-cd100 monoclonal antibodies have been developed to neutralize cd100.
Il22 immunoconjugates
Philogen S.p.a.
October 26, 2017 - N°20170305989

The application relates to a conjugate comprising interleukin-22 (il22) and an antibody molecule. The antibody molecule preferably binds an antigen associated with angiogenesis, such as the ed-a isoform of fibronectin. In particular, the application relates to the therapeutic use of such conjugates in the treatment of a disease/disorder, such as autoimmune diseases, including inflammatory bowel disease (ibd).
Fused pentacyclic imidazole derivatives
Sanofi
October 26, 2017 - N°20170305932

A series of fused pentacyclic imidazole derivatives, being potent modulators of human tnfa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders. In particular, the present invention is concerned with 6,7-dihydro-7,14-methanobenzimidazo[1,2...
Crystalline forms of a bruton's tyrosine kinase inhibitor
Pharmacyclics Llc
October 26, 2017 - N°20170305919

Described herein is the bruton's tyrosine kinase (btk) inhibitor 1-((r)-3-(4-amino-3-(4-phenoxyphenyl)-1h-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one, including crystalline forms, solvates and pharmaceutically acceptable salts thereof. Also disclosed are pharmaceutical compositions that include the btk inhibitor, as well as methods of using the btk inhibitor, alone or in combination with other ...
Loading